A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
2,5-Dimethoxyamphetamine
Imagabalin
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Imagabalin.
2,5-Dimethoxyamphetamine
Tetrahydropalmatine
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Tetrahydropalmatine.
2,5-Dimethoxyamphetamine
Idalopirdine
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Idalopirdine.
2,5-Dimethoxyamphetamine
Lanicemine
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Lanicemine.
2,5-Dimethoxyamphetamine
Etiracetam
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Etiracetam.
2,5-Dimethoxyamphetamine
Brexanolone
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Brexanolone.
2,5-Dimethoxyamphetamine
Tetrahydrocannabivarin
The risk or severity of adverse effects can be increased when Lasmiditan is combined with Tetrahydrocannabivarin.
2,5-Dimethoxyamphetamine
Tropisetron
The risk or severity of adverse effects can be increased when Tropisetron is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Iferanserin
The risk or severity of adverse effects can be increased when Iferanserin is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Psilocybin
The risk or severity of adverse effects can be increased when Psilocybin is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Thiocolchicoside
The risk or severity of adverse effects can be increased when Thiocolchicoside is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Detomidine
The risk or severity of adverse effects can be increased when Detomidine is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Zolazepam
The risk or severity of adverse effects can be increased when Zolazepam is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Tricaine
The risk or severity of adverse effects can be increased when Tricaine is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Tiletamine
The risk or severity of adverse effects can be increased when Tiletamine is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Romifidine
The risk or severity of adverse effects can be increased when Romifidine is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Propiopromazine
The risk or severity of adverse effects can be increased when Propiopromazine is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Xylazine
The risk or severity of adverse effects can be increased when Xylazine is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Medetomidine
The risk or severity of adverse effects can be increased when Medetomidine is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Doramectin
The risk or severity of adverse effects can be increased when Doramectin is combined with Lasmiditan.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3